BPH - Benign Prostatic Enlargement - Results from #500

REVIEW UroToday

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). June 5, 2022

PSA density is associated with BPH cellular composition. June 5, 2022

Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study. May 29, 2022

Recommendations for the Management of Patients with Benign Prostatic Hyperplasia in the Context of the COVID-19 Pandemic: A Retrospective Study of 314 Cases. May 29, 2022

Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezūm® steam system. May 22, 2022

A prospective randomized controlled trial comparing the effect and safety of Piranha and VersaCut morcellation devices in transurethral holmium laser enucleation of the prostate. May 22, 2022

Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. May 16, 2022

Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary? May 15, 2022

Prostate diseases and microbiome in the prostate, gut, and urine. May 9, 2022

The comparison study of anatomic vapor-incision technique (AVIT) using the 180W-XPS Greenlight laser and photoselective vaporization of the prostate(PVP) for the treatment of benign prostatic hyperplasia. May 8, 2022

Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score-matched analysis. May 8, 2022

Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. May 2, 2022

Rezūm therapy for ≥ 80 ml benign prostatic enlargement: a large, multi-center cohort study. May 1, 2022

WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates. May 1, 2022

Do men with bladder stones benefit from treatment of benign prostatic obstruction (BPO)? May 1, 2022

Transurethral plasmakinetic resection versus enucleation for benign prostatic hyperplasia: comparison of intraoperative safety profiles based on endoscopic surgical monitoring system. April 25, 2022

Comparison of the efficacy and safety of transurethral laser versus open prostatectomy for patients with large-sized benign prostatic hyperplasia: A meta-analysis of comparative trials. April 25, 2022

[Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)]. April 24, 2022

The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction. April 18, 2022

Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging. April 18, 2022

Page 26 of 140